Ireland - English - HPRA (Health Products Regulatory Authority)

meda health sales ireland limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - 137/50 microgram(s) - corticosteroids; fluticasone, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - 137mcg/50 microgram(s) - corticosteroids; fluticasone, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris healthcare limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - corticosteroids; fluticasone, combinations

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

janssen pharmaceutica (pty) ltd - nasal spray - not indicated - none

Ireland - English - HPRA (Health Products Regulatory Authority)

haleon ireland limited - fluticasone propionate (micronised) - nasal spray, suspension - 50 mcg/acutuation - corticosteroids; fluticasone

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - gonadorelin 200ug - nasal spray solution - 200 mcg/dose - active: gonadorelin 200ug

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - esketamine hcl 32.2mg eqv. to esketamine - spray - esketamine hcl 32.2mg eqv. to esketamine 28mg/vial

Canada - English - Health Canada

apotex inc - fluticasone propionate - spray, metered dose - 50mcg - fluticasone propionate 50mcg - corticosteroids

United States - English - NLM (National Library of Medicine)

proficient rx lp - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - fluticasone propionate nasal spray, usp is indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adult and pediatric patients aged 4 years and older. fluticasone propionate nasal spray is contraindicated in patients with hypersensitivity to any of its ingredients [see warnings and precautions (5.3), description (11)] . teratogenic effects pregnancy category c. there are no adequate and well-controlled trials with fluticasone propionate nasal spray in pregnant women. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. because animal reproduction studies are not always predictive of human response, fluticasone propionate nasal spray should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. women should be advised to contact their physicians if they become pregnant while taking fluticasone propionate nasal spray. mice and rats at fluticasone propiona

United States - English - NLM (National Library of Medicine)

quality care products, llc - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - fluticasone propionate nasal spray, usp is indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adult and pediatric patients aged 4 years and older. fluticasone propionate nasal spray is contraindicated in patients with hypersensitivity to any of its ingredients [see warnings and precautions (5.3), description (11)] . teratogenic effects pregnancy category c. there are no adequate and well-controlled trials with fluticasone propionate nasal spray in pregnant women. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. because animal reproduction studies are not always predictive of human response, fluticasone propionate nasal spray should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. women should be advised to contact their physicians if they become pregnant while taking fluticasone propionate nasal spray. mice and rats at fluticasone propiona